An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain.
Bottom Line: These data were used to generate the overarching study outcome, which was a recommendation for a strategy for drug safety surveillance congruent with existing literature on counterfeit medication.Importantly, the information generated by these analyses could be utilised to identify at-risk populations associated with demographic characteristics.Stakeholders should explore these results as another tool to improve on counterfeit medicine surveillance.
Affiliation: Global Health Policy Institute, La Jolla, California, USA Joint Doctoral Program in Global Public Health, University of California, San Diego-San Diego State University, San Diego, California, USA.Show MeSH
Related in: MedlinePlus
Mentions: The comparison of a point density map for wave 1 notices to a point density map for wave 2 notices shows that wave 1 notices were more concentrated in Southern California (figure 3A), whereas wave 2 notices exhibited greater concentrations in the eastern half of the country (figure 3B). This indicates that the distribution of FDA warning notices was geographically distinct and needs to be analysed further for differences. A subsequent cluster and outlier analysis showed clusters of high numbers of individuals over age 65 for metropolitan areas in Southern California, the New York metropolitan area, and the Miami metropolitan area (figure 4).
Affiliation: Global Health Policy Institute, La Jolla, California, USA Joint Doctoral Program in Global Public Health, University of California, San Diego-San Diego State University, San Diego, California, USA.